Mintr Compass
$544.59
VRTX · Vertex Pharmaceuticals
94 Top-Tier · Mid Horizon
94Top-Tier
Price Action76
Business Quality61
Market Confidence67
AI READ as of 2026-08-20
Trading Strong
  • Price is currently positioned very close to recent peaks
  • The asset is showing greater resilience than the broader market
  • Recent price movement patterns suggest underlying upward pressure
Investing Firming
  • The company maintains a very healthy financial cushion
  • Professional observers maintain a generally positive outlook on the business
  • The healthcare industry provides a stable backdrop for long-term operations
Price & Momentum · Trading
Technical
52
Rel. Strength
82
Momentum
75
Proximity
95
Sentiment
57
Business & Value · Investing
Quality
73
Balance Sheet
87
Growth
60
Valuation
22
Analyst
77
Open VRTX in Compass →
Ratings current as of 2026-08-19. Price live as of 2026-08-20 14:30 UTC. Algorithmic percentile rankings from historical and delayed data — not investment advice or a recommendation to buy or sell any security. Markets involve risk including loss of principal. Methodology · Terms · Privacy